87 related articles for article (PubMed ID: 31117872)
1. sCLU as prognostic biomarker and therapeutic target in osteosarcoma.
Ma J; Gao W; Gao J
Bioengineered; 2019 Dec; 10(1):229-239. PubMed ID: 31117872
[TBL] [Abstract][Full Text] [Related]
2. Tumor-oriented and chemo-photothermal nanoplatform capable of sensitizing chemotherapy and ferroptosis against osteosarcoma metastasis.
Wu H; Li B; Shao J; Kong Q
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132019. PubMed ID: 38729498
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26032. PubMed ID: 21998749
[TBL] [Abstract][Full Text] [Related]
4. Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.
Zoubeidi A; Chi K; Gleave M
Clin Cancer Res; 2010 Feb; 16(4):1088-93. PubMed ID: 20145158
[TBL] [Abstract][Full Text] [Related]
5. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.
Trougakos IP; Lourda M; Antonelou MH; Kletsas D; Gorgoulis VG; Papassideri IS; Zou Y; Margaritis LH; Boothman DA; Gonos ES
Clin Cancer Res; 2009 Jan; 15(1):48-59. PubMed ID: 19118032
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26033. PubMed ID: 22016805
[TBL] [Abstract][Full Text] [Related]
7. ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth.
Li J; Zhao C; Wang D; Wang S; Dong H; Wang D; Yang Y; Li J; Cui F; He X; Qin J
Cancer Immunol Immunother; 2023 Apr; 72(4):903-916. PubMed ID: 36161509
[TBL] [Abstract][Full Text] [Related]
8. Exosomes in osteosarcoma research and preclinical practice.
Zhang XB; Zhang RH; Su X; Qi J; Hu YC; Shi JT; Zhang K; Wang KP; Zhou HY
Am J Transl Res; 2021; 13(3):882-897. PubMed ID: 33841628
[TBL] [Abstract][Full Text] [Related]
9. A short-term three dimensional culture-based drug sensitivity test is feasible for malignant bone tumors.
Goto H; Ohtsu T; Ito M; Sagisaka M; Naruto T; Nagai JI; Kitagawa N; Tanaka M; Yanagimachi M; Hiroshima Y; Miyagi Y
Hum Cell; 2023 Nov; 36(6):2152-2161. PubMed ID: 37707773
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Clusterin Inhibition in Human Cancer.
Martín-García D; García-Aranda M; Redondo M
Cells; 2024 Apr; 13(8):. PubMed ID: 38667280
[TBL] [Abstract][Full Text] [Related]
11. Clusterin Expression in Colorectal Carcinomas.
Téllez T; Martin-García D; Redondo M; García-Aranda M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834086
[TBL] [Abstract][Full Text] [Related]
12. Clusterin and Its Isoforms in Oral Squamous Cell Carcinoma and Their Potential as Biomarkers: A Comprehensive Review.
Zhang Q; Teow JY; Kerishnan JP; Abd Halim AA; Chen Y
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239129
[TBL] [Abstract][Full Text] [Related]
13. Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment.
Yang P; Yang Z; Dong Y; Yang L; Peng S; Yuan L; Hu X; Chen S; Tang H; Yang X; Fan D; Zhao H; Bao G
Transl Cancer Res; 2023 Jan; 12(1):31-45. PubMed ID: 36760385
[TBL] [Abstract][Full Text] [Related]
14. A pan-cancer analysis reveals role of clusterin (
Fu Y; Du Q; Cui T; Lu Y; Niu G
Front Genet; 2022; 13():1056184. PubMed ID: 36685863
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic and prognostic role of clusterin in diverse musculoskeletal diseases: a mini review.
Zhang K; Liu K; Yu D; Tang Y; Geng B; Xia Y; Xu P
Physiol Res; 2022 Dec; 71(6):739-747. PubMed ID: 36281729
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis.
Huang S; Li X; Gu W; Li X; Zhao J; Wu J; Cai J; Feng X; Tao T
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626071
[TBL] [Abstract][Full Text] [Related]
17. Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis.
Visconti VV; Greggi C; Cariati I; Gasperini B; Mastrogregori A; Botta A; Tarantino U
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456459
[TBL] [Abstract][Full Text] [Related]
18. Pleckstrin homology-like domain family A, member 3, a miR-19a-3p-regulated gene, suppresses tumor growth in osteosarcoma by downregulating the Akt pathway.
Wang P; Huang Y; Xia X; Han J; Zhang L; Zhao W
Bioengineered; 2022 Feb; 13(2):3993-4009. PubMed ID: 35112982
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma and Metastasis.
Sheng G; Gao Y; Yang Y; Wu H
Front Oncol; 2021; 11():780264. PubMed ID: 34956899
[TBL] [Abstract][Full Text] [Related]
20. The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review.
Tan J; Guo W; Yang S; Han D; Li H
Transl Lung Cancer Res; 2021 Jun; 10(6):2683-2697. PubMed ID: 34295670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
